2022
DOI: 10.1007/s10928-022-09815-x
|View full text |Cite
|
Sign up to set email alerts
|

A quantitative systems pharmacology model of plasma potassium regulation by the kidney and aldosterone

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
9
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
4
2

Relationship

0
6

Authors

Journals

citations
Cited by 10 publications
(9 citation statements)
references
References 42 publications
0
9
0
Order By: Relevance
“…The model currently includes limited physiological detail (e.g., GI compartments) and limited detail on the complexity of K + regulation; this could be expanded upon in the future using information from literature based on detailed physiological experiments and data from large trials of drugs that influence K + handling (e.g., aldosterone antagonists), as explored by Stadt et al 18 . and Maddah and Hallow 17 . Such refinement would improve the fidelity of the model in capturing sK + trends at the highest and lowest ends, where underlying regulatory systems are likely not working optimally.…”
Section: Discussionmentioning
confidence: 99%
“…The model currently includes limited physiological detail (e.g., GI compartments) and limited detail on the complexity of K + regulation; this could be expanded upon in the future using information from literature based on detailed physiological experiments and data from large trials of drugs that influence K + handling (e.g., aldosterone antagonists), as explored by Stadt et al 18 . and Maddah and Hallow 17 . Such refinement would improve the fidelity of the model in capturing sK + trends at the highest and lowest ends, where underlying regulatory systems are likely not working optimally.…”
Section: Discussionmentioning
confidence: 99%
“…Youn et al [33] used two-compartment and three-compartment models to analyze fluxes of K + between the extracellular and intracellular space as well as K + uptake by red blood cells. Maddah and Hallow [34] developed a quantitative systems pharmacology model that captures the effect of aldosterone on K + homeostasis to simulate the effects of spironolactone treatment in patients with hyperaldosteronism.…”
Section: Discussionmentioning
confidence: 99%
“…To model [ALD], denoted by C al , we use the approach developed by Maddah & Hallow [11]: where m K − aldo is a fitting parameter and is the total extracellular fluid [K + ] given by and is the baseline extracellular [K + ]. We capture the effect of [ALD] on Na + -K + -ATPase abundance by the scaling factor ρ al (see Eq.…”
Section: Methodsmentioning
confidence: 99%